These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 24969665)
1. Zinc phthalocyanine conjugated with the amino-terminal fragment of urokinase for tumor-targeting photodynamic therapy. Chen Z; Xu P; Chen J; Chen H; Hu P; Chen X; Lin L; Huang Y; Zheng K; Zhou S; Li R; Chen S; Liu J; Xue J; Huang M Acta Biomater; 2014 Oct; 10(10):4257-68. PubMed ID: 24969665 [TBL] [Abstract][Full Text] [Related]
2. A drug carrier targeting murine uPAR for photodynamic therapy and tumor imaging. Zhou X; Zheng K; Li R; Chen Z; Yuan C; Hu P; Chen J; Xue J; Huang M Acta Biomater; 2015 Sep; 23():116-126. PubMed ID: 26004218 [TBL] [Abstract][Full Text] [Related]
3. A novel tumor targeting drug carrier for optical imaging and therapy. Li R; Zheng K; Hu P; Chen Z; Zhou S; Chen J; Yuan C; Chen S; Zheng W; Ma E; Zhang F; Xue J; Chen X; Huang M Theranostics; 2014; 4(6):642-59. PubMed ID: 24723985 [TBL] [Abstract][Full Text] [Related]
4. Amino-terminal fragment of urokinase inhibits tumor cell invasion in vitro and in vivo: respective contribution of the urokinase plasminogen activator receptor-dependent or -independent pathway. Li H; Soria C; Griscelli F; Opolon P; Soria J; Yeh P; Legrand C; Vannier JP; Belin D; Perricaudet M; Lu H Hum Gene Ther; 2005 Oct; 16(10):1157-67. PubMed ID: 16218777 [TBL] [Abstract][Full Text] [Related]
5. Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator. Mohanam S; Chandrasekar N; Yanamandra N; Khawar S; Mirza F; Dinh DH; Olivero WC; Rao JS Oncogene; 2002 Nov; 21(51):7824-30. PubMed ID: 12420219 [TBL] [Abstract][Full Text] [Related]
6. A hybrid protein comprising ATF domain of pro-UK and VAS, an angiogenesis inhibitor, is a potent candidate for targeted cancer therapy. Sun Q; Xu Q; Dong X; Cao L; Huang X; Hu Q; Hua ZC Int J Cancer; 2008 Aug; 123(4):942-50. PubMed ID: 18528863 [TBL] [Abstract][Full Text] [Related]
7. A tumor-targeted Ganetespib-zinc phthalocyanine conjugate for synergistic chemo-photodynamic therapy. Huang L; Wei G; Sun X; Jiang Y; Huang Z; Huang Y; Shen Y; Xu X; Liao Y; Zhao C Eur J Med Chem; 2018 May; 151():294-303. PubMed ID: 29627724 [TBL] [Abstract][Full Text] [Related]
8. Novel theranostic zinc phthalocyanine-phospholipid complex self-assembled nanoparticles for imaging-guided targeted photodynamic treatment with controllable ROS production and shape-assisted enhanced cellular uptake. Ma J; Li Y; Liu G; Li A; Chen Y; Zhou X; Chen D; Hou Z; Zhu X Colloids Surf B Biointerfaces; 2018 Feb; 162():76-89. PubMed ID: 29154189 [TBL] [Abstract][Full Text] [Related]
9. DOT corrected fluorescence molecular tomography using targeted contrast agents for small animal tumor imaging. Tan Y; Cao Z; Sajja HK; Lipowska M; Wang YA; Yang L; Jiang H J Xray Sci Technol; 2013; 21(1):43-52. PubMed ID: 23507851 [TBL] [Abstract][Full Text] [Related]
10. cDNA transfection of amino-terminal fragment of urokinase efficiently inhibits cancer cell invasion and metastasis. Zhu F; Jia S; Xing G; Gao L; Zhang L; He F DNA Cell Biol; 2001 May; 20(5):297-305. PubMed ID: 11410166 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of peptide-conjugated phthalocyanine photosensitizers with highly hydrophilic modifications. Li F; Liu Q; Liang Z; Wang J; Pang M; Huang W; Wu W; Hong Z Org Biomol Chem; 2016 Apr; 14(13):3409-22. PubMed ID: 26956169 [TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy and nuclear imaging activities of zinc phthalocyanine-integrated TiO Yurt F; Ocakoglu K; Ince M; Colak SG; Er O; Soylu HM; Gunduz C; Biray Avci C; Caliskan Kurt C Chem Biol Drug Des; 2018 Mar; 91(3):789-796. PubMed ID: 29136341 [TBL] [Abstract][Full Text] [Related]
14. [Experimental study of anti-metastasis effect of urokinase amino-terminal fragment gene on human breast cancer cells]. Zhu F; Xing G; He F Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):115-7. PubMed ID: 11783013 [TBL] [Abstract][Full Text] [Related]
15. A tumor-targeted activatable phthalocyanine-tetrapeptide-doxorubicin conjugate for synergistic chemo-photodynamic therapy. Ke MR; Chen SF; Peng XH; Zheng QF; Zheng BY; Yeh CK; Huang JD Eur J Med Chem; 2017 Feb; 127():200-209. PubMed ID: 28063352 [TBL] [Abstract][Full Text] [Related]
16. Core-interlayer-shell Fe Liu G; Ma J; Li Y; Li Q; Tan C; Song H; Cai S; Chen D; Hou Z; Chen Q; Zhu X Int J Pharm; 2017 Apr; 521(1-2):19-32. PubMed ID: 28163230 [TBL] [Abstract][Full Text] [Related]
17. Methylsulfonyl Zn phthalocyanine: A polyvalent and powerful hydrophobic photosensitizer with a wide spectrum of photodynamic applications. İşci Ü; Beyreis M; Tortik N; Topal SZ; Glueck M; Ahsen V; Dumoulin F; Kiesslich T; Plaetzer K Photodiagnosis Photodyn Ther; 2016 Mar; 13():40-47. PubMed ID: 26529064 [TBL] [Abstract][Full Text] [Related]
18. Investigation of in vitro PDT activities of zinc phthalocyanine immobilised TiO Yurt F; Ince M; Colak SG; Ocakoglu K; Er O; Soylu HM; Gunduz C; Avci CB; Kurt CC Int J Pharm; 2017 May; 524(1-2):467-474. PubMed ID: 28365390 [TBL] [Abstract][Full Text] [Related]
19. In vivo targeted deep-tissue photodynamic therapy based on near-infrared light triggered upconversion nanoconstruct. Cui S; Yin D; Chen Y; Di Y; Chen H; Ma Y; Achilefu S; Gu Y ACS Nano; 2013 Jan; 7(1):676-88. PubMed ID: 23252747 [TBL] [Abstract][Full Text] [Related]
20. Hexadecafluorinated zinc phthalocyanine: photodynamic properties against the EMT-6 tumour in mice and pharmacokinetics using 65Zn as a radiotracer. Boyle RW; Rousseau J; Kudrevich SV; Obochi M; van Lier JE Br J Cancer; 1996 Jan; 73(1):49-53. PubMed ID: 8554982 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]